Pharma Journalist - Page 7 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Pfizer Licenses Chai AI Platform for Drug Discovery

Cellares, TScan Partner on Automated TSC-101 Manufacturing

Massive Bio, Optellum Partner to Advance Lung Cancer Trial Access

FDA Grants Priority Review to Roche’s Giredestrant

EU Approves AQUIPTA for Acute Migraine Treatment

Contraline Raises $92.5 Million for Male Contraceptive Development

CytomX, Regeneron Expand Bispecific Cancer Therapy Alliance

Travere Licenses Kidney Disease Drug in Billion-Dollar Deal

Phase 3 Success Boosts Prospects for Iza-Bren

Vertex Kidney Disease Drug Faces FDA Decision in November